Xue Wu

3.7k total citations
104 papers, 2.1k citations indexed

About

Xue Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xue Wu has authored 104 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 21 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Xue Wu's work include RNA modifications and cancer (10 papers), CRISPR and Genetic Engineering (7 papers) and RNA and protein synthesis mechanisms (7 papers). Xue Wu is often cited by papers focused on RNA modifications and cancer (10 papers), CRISPR and Genetic Engineering (7 papers) and RNA and protein synthesis mechanisms (7 papers). Xue Wu collaborates with scholars based in China, United States and Macao. Xue Wu's co-authors include Mircea Ivan, Yang Yang, Bin Yu, Chau‐Wen Tseng, Dahai Hu, M. Franklin, Aamer Jaleel, Donald Yeung, Bruce Jacob and Zhishu Tang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Xue Wu

99 papers receiving 2.1k citations

Peers

Xue Wu

ONCOL

PRM

IMMUN

Junseong Park South Korea

Qing Yu United States

Qingqing Liu China

Ying Zhou China

Taher Abbasi United States

Bing Han China

Yumin Wang China

Zhigang Hu China

Lianyu Chen China

Junseong Park South Korea

Xue Wu

1.3k ×1.1

568 ×1.1

355 ×1.4

ONCOL

146 ×0.7

PRM

265 ×1.3

IMMUN

Citations per year, relative to Xue Wu Xue Wu (= 1×) peers Junseong Park

Countries citing papers authored by Xue Wu

Since Specialization

Citations

This map shows the geographic impact of Xue Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Wu more than expected).

Fields of papers citing papers by Xue Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Wu. The network helps show where Xue Wu may publish in the future.

Co-authorship network of co-authors of Xue Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Wu. A scholar is included among the top collaborators of Xue Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Wu. Xue Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xue, et al.. (2025). NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker. Cancer Science. 116(9). 2400–2412.

Wu, Xue, Yupeng Liu, Bingzhe Wang, et al.. (2025). Rationally assembling different surface functionalized carbon dots for enhanced near-infrared tumor photothermal therapy. Acta Physico-Chimica Sinica. 41(9). 100109–100109. 1 indexed citations

Li, Lingyun, Jun Wu, Xue Wu, et al.. (2025). Carbon Dot‐Linked Hydrogel for TAMs Transform: Spatiotemporal Manipulation to Reshape Tumor Microenvironment. Advanced Materials. 37(20). e2420068–e2420068. 7 indexed citations

Zhang, Jun, Yifan Tian, Hao Yan, et al.. (2025). Protective effect and mechanism of plant-derived Lactobacillus G11 on septic myocardial injury. International Immunopharmacology. 148. 114021–114021.

Lü, Yufang, Xue Wu, Jin Liu, et al.. (2025). Baicalin ameliorates neuroinflammation by targeting TLR4/MD2 complex on microglia via PI3K/AKT/NF-κB signaling pathway. Neuropharmacology. 267. 110296–110296. 4 indexed citations

Zhou, Yuying, et al.. (2024). GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer. Breast Cancer Targets and Therapy. Volume 16. 71–89. 1 indexed citations

Zhang, Xin, Ge Wang, Xiaoru Li, et al.. (2024). LncRNA H19 Promotes Gastric Cancer Metastasis via miR‐148‐3p/SOX‐12 Axis. Analytical Cellular Pathology. 2024(1). 6217134–6217134. 1 indexed citations

Zhao, Huadong, Ying Chen, Qian Lu, et al.. (2023). Lycorine protects against septic myocardial injury by activating AMPK-related pathways. Free Radical Biology and Medicine. 197. 1–14. 12 indexed citations

Chen, Ying, Junmin Chen, Zhao Lin, et al.. (2023). Ethyl pyruvate attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells: Role of GAS6/Axl signaling. Heliyon. 9(12). e22787–e22787. 3 indexed citations

10.

Wang, Xue, Zhenxing Liang, Qiong Liu, et al.. (2023). Identification of PIK3R5 as a hub in septic myocardial injury and the cardioprotective effects of Psoralidin. Phytomedicine. 122. 155146–155146. 4 indexed citations

11.

Li, Jin, Xue Wu, Shijun Zhang, et al.. (2022). Subpathway Analysis of Transcriptome Profiles Reveals New Molecular Mechanisms of Acquired Chemotherapy Resistance in Breast Cancer. Cancers. 14(19). 4878–4878. 15 indexed citations

12.

Zeng, Zhi, Xu Zhang, Congqing Jiang, et al.. (2022). Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening. Oncogene. 41(14). 2069–2078. 20 indexed citations

13.

Wu, Xue, et al.. (2022). DSCN: Double-target selection guided by CRISPR screening and network. PLoS Computational Biology. 18(8). e1009421–e1009421. 1 indexed citations

14.

Li, Jin, Xue Wu, Zhi Jiang Zeng, et al.. (2020). Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy. Biology. 9(9). 278–278. 11 indexed citations

15.

Chen, Fangli, Xue Wu, Marilena Gîlcă, et al.. (2020). Classic and targeted anti‐leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications. Journal of Cellular and Molecular Medicine. 24(13). 7378–7392. 10 indexed citations

16.

Peng, Xiaoxiao, Ruoying Yu, Xue Wu, et al.. (2020). Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000376–e000376. 146 indexed citations

17.

Wang, Zheng, Dong-Bo Zhang, Xue Wu, et al.. (2019). Protective Effects of Polysaccharide Extracted from Portulacae oleracea L. on Colitis Induced by Dextran Sulfate Sodium. Journal of Medicinal Food. 23(2). 125–131. 18 indexed citations

18.

Merfeld‐Clauss, Stephanie, Hongyan Lu, Xue Wu, Keith L. March, & Dmitry O. Traktuev. (2017). Hypoxia‐induced activin A diminishes endothelial cell vasculogenic activity. Journal of Cellular and Molecular Medicine. 22(1). 173–184. 9 indexed citations

19.

Hang, Zhang, et al.. (2015). Multi-source and Heterogeneous Data Aggregation Method for Power Transmission and Transformation Equipment Panoramic Information. Gao dianya jishu. 3888–3894. 4 indexed citations

20.

Wu, Xue. (2000). Analysis of katG gene mutations in M tuberculosis isolates by direct sequencing. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact